AT

Agape ATP Corporation

ATPCConsumer DefensiveNASDAQ

Packaged Foods · Last scanned Jul 22, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.5M
+15.2% YoY
Net Income
-$2.3M
+7.7% YoY
EBITDA
-$3.0M
-29.1% YoY
Free Cash Flow
$935,830

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 15 RSI OversoldRSI 19.6, below 30, stock may be oversold
Jul 14 RSI OversoldRSI 14.3, below 30, stock may be oversold
About Agape ATP Corporation

Part of the consumer defensive sector, Agape ATP Corporation (ATPC) is listed under Packaged Foods. Valued at $2.6M, ATPC is a micro-cap name in its sector. The company operates in two segments, Skin care, health and wellness; and Green energy.

Where ATPC stands vs its 150-day and 200-day moving averages

As of the July 15, 2026 close, ATPC finished 42.73% below its 150-day moving average ($4.54) and 86.31% below its 200-day moving average ($18.99). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ATPC overbought or oversold?

At the July 15, 2026 close, ATPC's RSI(14) was 19.6, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$2.6M
P/E (TTM)5.86
EPS$0.44
Beta0.41
52W Change-96.2%
ROE-8.4%
Analysis

With $24.3M in cash and $180K in debt, ATPC maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $936K in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -8.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $1.9M (2022) to $1.5M (2025), a 18% decline worth watching.

The relatively low beta of 0.41 suggests ATPC is a less volatile holding compared to the broader index. With cash comfortably exceeding debt, ATPC has financial flexibility that may help navigate uncertain periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ATPC.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms
ATPC: Agape ATP Corporation Technical Analysis (200-Day MA, RSI, MACD) | Scanance